P. Lavtar

发表

Angiotensin-converting enzyme insertion/deletion gene polymorphism and interferon-&bgr; treatment response in multiple sclerosis patients: a preliminary report

B. Peterlin, O. Perković, S. Ristić, 2017, Pharmacogenetics and genomics.

Identification of rare genetic variation of NLRP1 gene in familial multiple sclerosis

G. Zamolo, B. Peterlin, A. Maver, 2017, Scientific Reports.

MMP-2 −1575G/A polymorphism modifies the onset of optic neuritis as a first presenting symptom in MS?

B. Peterlin, O. Perković, S. Ristić, 2015, Journal of Neuroimmunology.

UNIVERSITY OF NOVA GORICA GRADUATE SCHOOL GENETICS BIOMARKERS AT MULTIPLE SCLEROSIS DISSERTATION

B. Peterlin, P. Lavtar, Polona Lavtar, 2013 .

CTLA‐4 +49 A/G gene polymorphism in Croatian and Slovenian multiple sclerosis patients

B. Peterlin, S. Ristić, J. Sepčić, 2011, International journal of immunogenetics.

The lack of association between angiotensin‐converting enzyme gene insertion/deletion polymorphism and nicotine dependence in multiple sclerosis

B. Peterlin, A. Hodzic, S. Ristić, 2016, Brain and behavior.

Association of circadian rhythm genes ARNTL/BMAL1 and CLOCK with multiple sclerosis

B. Peterlin, A. Maver, A. Hodzic, 2018, PloS one.

Influence of CCR5Δ32 gene mutation on interferon-beta treatment response in multiple sclerosis

B. Peterlin, S. Ristić, L. Lovrečić, 2015 .

Identification of rare genetic variation of NLRP1 gene in familial multiple sclerosis

G. Zamolo, B. Peterlin, A. Maver, 2017, Scientific Reports.

The Role of TPA I/D and PAI-1 4G/5G Polymorphisms in Multiple Sclerosis

B. Peterlin, O. Perković, S. Ristić, 2014, Disease markers.